Extracorporeal Membrane Oxygenation (ECMO): Blood Cells

Spectrum Health Hospitals

Status: Terminated

Conditions: Extracorporeal Membrane Oxygenation

Treatments: Other: Blood specimen collection

Study type: Observational

Funder types: Other

Identifiers

NCT02748668

2014-255

Details and patient eligibility

About

The objective of the study is to predict outcomes of patients on extracorporeal membrane oxygenation (ECMO) therapy by correlating cytokines and inflammatory cell patterns to clinical outcomes using data collected in the ECMO Registry at Spectrum Health.

Enrollment: 371 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

ECMO group:

Inclusion Criteria:

• Greater than or equal to 18 years of age
• Subject presents to the CTICU at Butterworth Campus, Spectrum Health and is critically ill in the ICU needing ECMO therapy.

Exclusion Criteria:

• Subject is less than 18 years of age
• Known prisoner

Control Subjects:

Inclusion Criteria

• Greater than 18 years of age
• Without any known cardiovascular, lung, or autoimmune disease.

Exclusion Criteria:

• Less than or equal to 18 years of age
• Known cardiovascular, lung, or autoimmune disease

Trial design

371 participants in 2 patient groups

ECMO

Description:

No intervention. Blood specimen collection.

Treatment:

Other: Blood specimen collection

Control

Description:

No intervention. Blood specimen collection.

Treatment:

Other: Blood specimen collection